(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ENSAIO PARA MEDIR A POTÊNCIA DO PRODUTO FARMACÊUTICO DE TERAPIA GÊNICA

Em AnáliseInvention PatentPCT · US2021055200

Application data

Number

112023006336

Type

Invention Patent

Filing

10/15/2021

Publication

07/11/2023

PCT

US2021055200

Progress at the INPI

  1. Filing10/15/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 10/15/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/11/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PREVAIL THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

J. H. (pessoa física)

US

M. N. (pessoa física)

US

P. B. (pessoa física)

US

T. F. (pessoa física)

US

Y. D. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

63/092,189 · 10/15/2020

Abstract

A presente invenção refere-se a um ensaio baseado em células para determinar a potência de um vetor viral recombinante que expressa um transgene.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

07/11/2023

RPI 2740

Alteração de dados cadastrais

#1.1

04/18/2023

RPI 2728

Related

Same category

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.